Heart rate variability assessment early after acute myocardial infarction: Pathophysiological and prognostic correlates

Circulation

Volumn 93, Issue 7, 1996, Pages 1388-1395

  Singh, Narendra ^a   Mironov, Dmitry ^a   Armstrong, Paul W ^b   Ross, Allan M ^c   Langer, Anatoly ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

electrocardiography; heart rate; myocardial infarction; prognosis

Indexed keywords

BLOOD CLOTTING FACTOR 10A; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ARTICLE; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029876142     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.7.1388     Document Type: Article

References (40)

1. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
2. Rich MW, Saini JS, Kleiger RE, Carney RM, teVelde A, Freedland KE. Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol. 1988;62:714-717.
3. Kleiger RE, Miller JP, Krone RJ, Bigger JT. The independence of cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction. Am J Cardiol. 1990;65:408-411.
4. Farell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991;18:687-697.
5. Hayano J, Sakakibara Y, Yamada M, Ohte N, Fujmami T, Yokoyama K, Watanabe Y, Takata K. Decreased magnitude of heart rate spectral components in coronary artery disease: its relationship to angiographic severity. Circulation. 1990;81:1217-1224.
6. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol. 1992;69:891-898.
7. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992; 85:164-171.
8. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
9. Krucoff MW, Green CL, Langer A, Kiootwijk LJP, Trollinger KM, Sawchak ST, Wilderman NM, Veldkamp RF, Pope JE, Simoons ML, Granger CB, Armstrong PW. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. J Electrocardiol. 1994;26(suppl):249-255.
10. Langer A, Krucoff MW, Klootwijk P, Veldkamp R, Simoons ML, Granger C, Califf RM, Armstrong PW, for the GUSTO Investigators. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. J Am Coll Cardiol. 1995;25:1552-1557.
11. The GUSTO Angiographic Investigators. The effect of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
12. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase - clinical findings through hospital discharge. Circulation. 1987;76:142-154.
13. Dodge HT, Sandler H, Ballew DW, Lord JD. The use of biplane angiocardiography for the measurement of left ventricular volume in man. Am Heart J. 1960;60:762-776.
14. Luria MH, Sapoznikov D, Gilon D, Zagher D, Weinstein JM, Weiss T, Gotsman MS. Early heart rate variability alterations after acute myocardial infarction. Am Heart J. 1993;125:676-681.
15. Casolo GC, Stroder P, Signorini C, Calzolari F, Zucchini M, Balli E, Sulla A, Lazzerini S. Heart rate variability during the acute phase of myocardial infarction. Circulation. 1992;85:2073-2079.
16. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm - paradoxic or predictable? Circulation. 1993;88:296-306.
17. Braunwald E, Kim CB. Potential benefits of late reperfusion of infarcted myocardium: the open artery hypothesis. Circulation. 1993;88:2426-2436.
18. Flapan AD, Wright RA, Nolan J, Neilson JMM, Ewing DJ. Differing patterns of cardiac parasympathetic activity and their evolution in selected patients with a first myocardial infarction. J Am Coll Cardiol. 1993;21:926-931.
19. Bigger JT, La Rovere MT, Steinman RC, Fleiss JL, Rottman JN, Polnitzky LM, Schwartz PJ. Comparison of baroreceptor sensitivity and heart period variability after myocardial infarction. J Am Coll Cardiol. 1989;14:1511-1518.
20. Vaishnav S, Stevenson R, Marchant B, Lagi K, Ranjadayalan K, Timmis AD. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol. 1994;73:653-657.
21. Cook JR, Bigger JT, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol. 1991;17:480-484.
22. Niemela MJ, Airaksinen KEJ, Huikuri HV. Effect of beta-blockade on heart-rate variability in patients with coronary artery disease. J Am Coll Cardiol. 1994;23:1370-1377.
23. Zuanetti G, Latini R, Neilson JMM, Schwartz PJ, Ewing DJ, and the Antiarrhythmic Drug Evaluation Group (ADEG). Heart rate variability in patients with ventricular arrhythmias: effects of antiarrhythmic drugs. J Am Coll Cardiol. 1991;17:604-612.
24. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981; 213:220-222.
25. Junker A, Mickley H, Moller M. Residual myocardial ischemia, 24-hour heart rate variability and cardiac events after first acute myocardial infarction. J Am Coll Cardiol. 1994;23:65A. Abstract.
26. Marchant B, Stevenson R, Vaishnav S, Ranjadayalan K, Timmis AD. Silent ischemia and autonomic function early after myocardial infarction: a comparison with stable angina. J Am Coll Cardiol. 1994;23:320A. Abstract.
27. Coromilis J, Burns K, Glusman M, Blood DK, Lee J. Heart-rate variability is increased in patients with silent myocardial ischemia. J Am Coll Cardiol. 1994;23:319A. Abstract.
28. Bigger JT, Hoover CA, Steinman RC, Rolnitzky LM, Fleiss JL. Autonomic nervous system activity during myocardial ischemia in man estimated by power spectral analysis of heart period variability. Am J Cardiol. 1990;66:497-498.
29. Vardas PE, Skalidis EI, Simandirakis EN, Parthenakis FI, Manios EG, Kochiadakis GE. Autonomic changes before and during nocturnal ischemic episodes in patients with extended coronary heart disease. J Am Coll Cardiol. 1994;23:320A. Abstract.
30. Brouwer J, Portegies MJM, Haaksma J, vd Ven LLM, Viersma JW, Lie KI. Heart rate variability before, during, and after episodes of silent myocardial ischemia. J Am Coll Cardiol. 1994;23:320A. Abstract.
31. Langer A, Minkowitz J, Dorian P, Casella L, Harris L, Morgan CD, Armstrong PW. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. J Am Coll Cardiol. 1992;20:1313-1317.
32. Tzivoni D, Gavish A, Zin D, Gottlieb S, Moriel M, Keren A, Banai S, Stern S. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol. 1988;62:661-664.
33. Moss AJ, Goldstein RE, Hall J, Bigger JT, Fleiss JL, Greenberg H, Bodenheimer M, Krone RJ, Marcus FI, Wackers FJT, Benhorin J, Brown MW, Case R, Coromilas J, Dwyer EM, Gillespie JA, Gregory JJ, Kleiger R, Lichstein E, Parker JO, Raubertas RF, Stern S, Tzivoni D, Voorhees LV. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. JAMA. 1993;269:2379-2385.
34. Hermosillo AG, Dorado M, Casanova JM, DeLeon SP, Cossio J, Kersenovich S, Colin L, Iturralde P. Influence of infarct-related artery patency on the indexes of parasympathetic activity and prevalence of late potentials in survivors of acute myocardial infarction. J Am Coll Cardiol. 1993;22:695-706.
35. Pedretti RFE, Columbo E, Braga SS, Caru B. Effect of thrombolysis on heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. J Am Coll Cardiol. 1994;23:19-26.
36. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-492.
37. Pagani M, Lombardi F, Malliani A. Heart rate variability: disagreement on the markers of sympathetic and parasympathetic activities. J Am Coll Cardiol. 1993;22:951-954.
38. Malik M, Camm AJ. Components of heart rate variability: what they really mean and what we really measure. Am J Cardiol. 1993; 72:821-822.
39. De Ferrari GM, Mantica M, Vanoli E, Hull SS, Schwartz PJ. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol. 1993;22:1327-1334.
40. Vybiral T, Glaeser DH, Morris G, Hess KR, Yang K, Francis M, Pratt CM. Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction. J Am Coll Cardiol. 1993;22:1320-1326.